Monthly Income With Dividends In August 2024

Welcome to a new report of my Dividend Diary on the TEV Blog. Here, I report the development of a cash flow-oriented investment approach that focuses on generating a passive income through dividends. Against this background, the goal is not to outperform the market but to put food on the table through a regular income via dividends.

With the Dividend Diary, I document how a cash-flow investment approach can be part of well-balanced wealth management. To keep things simple, I have built three pillars:

• Active income.
• Passive income.
• Conversion.

Dividends fall into the last two categories. They are passive because they provide a cash flow without me going to work. Additionally, they are an essential pillar for conversion since they can be reinvested to generate even more income in the future. That is the Theory. Now let’s get down to practice.

My monthly income with dividends in August:

This month, my cash-flow approach generated the following income through dividends:

• AT&T (33.07 EUR)
• Bristol-Myers Squibb (42.12 EUR)
• CVS Health (21.23 EUR)
• General Mills (43.73 EUR)
• General Dynamics (15.54 EUR)
• Apple (7.80 EUR)
• AbbVie (43.69 EUR)
• Omega Healthcare (21.34 EUR)
• Procter & Gamble (20.45 EUR)
• Novo Nordisk (12.84 EUR)
• Realty Income (18.55 EUR)
• Williams-Sonoma (12.83 EUR)
• Main Street Capital (8.92 EUR).

So overall:

• the total monthly income with dividends in August (after taxes) was: € 302.22  / appr. $ 330,
• ⌀ monthly dividend income (ttm): € 543.37 / appr. $ 585,
• ⌀ monthly dividend income (ttm) compared to the previous month: + 0.55 percent.

Compared to last year, the performance was okay (+ 12.4 percent YoY). Overall, the development looks like this: